Dose-response of sodium bicarbonate ingestion highlights individuality in time course of blood analyte responses by Jones, RL et al.
1 
 
Dose-response of sodium bicarbonate ingestion highlights individuality in time course of blood 1 
analyte responses. 2 
 3 
AUTHORS: Rebecca Louise Stannard1, Trent Stellingwerff2, Guilherme Giannini Artioli3, Bryan 4 
Saunders3, Simon Cooper1 and Craig Sale1.  5 
 6 
AFFILIATIONS: 1Musculoskeletal Physiology Research Group, Sport, Health and Performance 7 
Enhancement (SHAPE) Research Centre, School of Science & Technology, Nottingham Trent 8 
University, UK. 2Canadian Sport Institute – Pacific, Victoria, Canada. 3Laboratory of Applied Nutrition 9 
& Metabolism, School of Physical Education, University of São Paulo, São Paulo, Brazil. 10 
 11 
CORRESPONDENCE:  Prof. Craig Sale. Musculoskeletal Physiology Research Group, Sport, Health 12 
and Performance Enhancement (SHAPE) Research Centre, Department of Sport Science, School of 13 
Science & Technology, Nottingham Trent University, UK, NG11 8NS.  14 
Telephone: +44 (0) 115 848 3505 15 
E-mail: craig.sale@ntu.ac.uk 16 
 17 
Running title: Dose-response to sodium bicarbonate ingestion   18 
2 
 
ABSTRACT 19 
To defend against hydrogen cation accumulation and muscle fatigue during exercise, sodium 20 
bicarbonate (NaHCO3) ingestion is commonplace. The individualised dose-response relationship 21 
between NaHCO3 ingestion and blood biochemistry is unclear. The present study investigated the 22 
bicarbonate, pH, base excess and sodium responses to NaHCO3 ingestion. Sixteen healthy males (23±2 23 
years; 78.6±15.1 kg) attended three randomised order-balanced, non-blinded sessions, ingesting a single 24 
dose of either 0.1, 0.2 or 0.3 g.kg-1BM of NaHCO3 (Intralabs, UK).  Fingertip capillary blood was 25 
obtained at baseline and every 10 min for 1 h, then every 15 min for a further 2 h. There was a significant 26 
main effect of both time and condition for all assessed blood analytes (P≤0.001). Blood analyte 27 
responses were significantly lower following 0.1 g.kg-1BM compared with 0.2 g.kg-1BM; bicarbonate 28 
concentrations and base excess were highest following ingestion of 0.3 g.kg-1BM (P≤0.01). Bicarbonate 29 
concentrations and pH significantly increased from baseline following all doses; the higher the dose the 30 
greater the increase. Large inter-individual variability was shown in the magnitude of the increase in 31 
bicarbonate concentrations following each dose (+2.0-5; +5.1-8.1; and +6.0-12.3 mmol·L-1 for 0.1, 0.2 32 
and 0.3 g.kg-1BM) and in the range of time to peak concentrations (30-150; 40-165; and 75-180 min for 33 
0.1, 0.2 and 0.3 g.kg-1BM). The variability in bicarbonate responses was not affected by normalisation 34 
to body mass. These results challenge current practices relating to NaHCO3 supplementation and clearly 35 
show the need for athletes to individualise their ingestion protocol and trial varying dosages prior to 36 
competition.   37 
 38 
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INTRODUCTION 40 
High-intensity exercise increases hydrogen cation (H+) production in the working muscle (Hill and 41 
Lupton, 1923).  The majority of these H+ are buffered, with only a small fraction being free in the 42 
cytosol to cause a decline in intracellular pH (Sahlin, 2014).  It has been proposed that the decreased 43 
intracellular pH is a critical factor in the development of fatigue during high-intensity exercise, either 44 
via a direct effect on the muscle contractile machinery or by disruption to muscle energetics (Fitts, 45 
1996). The ability to deal with this proton production is an important determinant of exercise 46 
performance and capacity. Two defence mechanisms against intramuscular acidosis are evident, 47 
namely, intramuscular physicochemical buffers and dynamic buffering (i.e., the ability to transport H+ 48 
out of the muscle and into the blood). Whilst the first line of defence is intramuscular physicochemical 49 
buffering, the main controller of pH during high-intensity exercise is dynamic buffering, this process 50 
allows the bicarbonate buffering system to minimise disruption to intramuscular pH (McNaughton et 51 
al. 2008; Carr et al. 2011) 52 
 53 
Supplementation with sodium bicarbonate (NaHCO3) increases the efflux of H+ out of the muscle and 54 
the extracellular buffering capacity, thus delaying the onset of muscle fatigue, and maintaining exercise 55 
performance (Cairns, 2006; Thomas et al. 2005). It is unsurprising that NaHCO3 ingestion has been a 56 
focus of researchers and athletes for over 30 years (Matson & Tran, 1993; Linderman & Gaosselink, 57 
1994), with mixed findings in regards to the ergogenic efficacy of NaHCO3 (for review see Peart et al. 58 
2012). Some of these differences might be explained by differences dosing strategies. Several dosing 59 
strategies are employed within with the sporting field, with NaHCO3 doses of 0.2-0.5 g.kg-1BM being 60 
consumed to enhance exercise performance (McNaughton et al. 1991). Nonetheless, ingestion of 0.3 61 
g.kg-1BM is most commonplace, consumed 60-90 min prior to exercise (Renfree, 2007; Price & Singh, 62 
2008; Siegler et al. 2010) in flavoured water or capsules (Peart et al. 2012). Consumption of 0.3 g.kg-63 
1BM typically increases blood bicarbonate concentrations by ~5–6 mmol.L-1 from baseline (Matson & 64 
Tran, 1993; Price et al. 2003; Robergs et al. 2005; Saunders et al. 2014; Miller et al. in press), which 65 
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has been suggested to enhance the buffering process sufficiently to result in an ergogenic benefit (Carr 66 
et al. 2011).  67 
 68 
Ingestion strategies can result in significant alterations in blood parameters, with peak acid-base 69 
disturbances occurring between 60 and 90 min post ingestion of 0.3 g.kg-1BM of NaHCO3 (Renfree, 70 
2007; Price & Singh, 2008; Siegler et al. 2010). Although there remains uncertainty as to how different 71 
doses affect the inter-individual variability in blood acid-base responses. Siegler et al. (2010) showed 72 
that blood bicarbonate peaked 65 min post ingestion of 0.3 g.kg-1BM, although due to blood samples 73 
assessed at 20 min intervals some important aspects of the temporal pattern in acid-base responses might 74 
have been overlooked. It has been proposed that the blood buffering responses to NaHCO3 ingestion 75 
are highly individual (Peart et al. 2012; Saunders et al. 2014b) and in order to optimise ergogenic 76 
potential, individualising the timing of exercise based on acid-base responses to NaHCO3 ingestion 77 
should be undertaken (Miller et al. in press). This highlights the need to examine how individuals 78 
respond to varying NaHCO3 doses.  79 
 80 
NaHCO3 ingestion can result in gastrointestinal (GI) distress (Carr et al. 2011; Siegler et al. 2012; Peart 81 
et al. 2012), with 10% of participants not tolerating the doses needed to gain a beneficial performance 82 
effect (McNaughton et al. 2008). As dose increases, GI discomfort is more commonplace, often without 83 
additional performance improvements (McNaughton, 1991; Kahle et al. 2013). To combat GI 84 
symptoms, stacking dose strategies has been implemented (Sale et al. 2011; Saunders et al. 2014a); 85 
splitting larger doses (0.3 g.kg-1BM) into smaller separate doses across a longer timeframe (0.2 g.kg-86 
1BM followed by 0.1 g.kg-1BM). How blood bicarbonate concentrations are altered following different 87 
dosages of NaHCO3 requires further investigation.  88 
 89 
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Therefore, the present study investigated bicarbonate, pH, base excess and sodium (Na+) responses to 90 
three different doses of NaHCO3 to determine the time course of changes and the inter-individual 91 
variability in responses.   92 
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METHODS 93 
Participants  94 
Eighteen participants volunteered to participate in this non-blinded, order-balanced, crossover study. 95 
Two participants withdrew due to GI distress, meaning that sixteen healthy males (age, 23±2 years; 96 
height, 1.80±0.07 m; body mass, 78.6±15.1 kg) completed all aspects of the study. Participants provided 97 
written informed consent and completed a health screen questionnaire prior to taking part in the study, 98 
which was first approved by the Nottingham Trent University Ethical Advisory Committee. Participants 99 
had not ingested any nutritional supplement or suffered from any GI problems in the previous 6 months.  100 
 101 
Protocol and measurements 102 
Participants attended three supplementation sessions at the same time of day, in at least a 4 h post-103 
prandial state and having replicated 24 h dietary intake. Participants were instructed to abstain from 104 
alcohol and strenuous/unaccustomed exercise for 24 h prior to each assessment, with caffeine prohibited 105 
on test days. Compliance with these requests was verbally confirmed prior to each session. Participants 106 
ingested a single dose of either 0.1, 0.2 or 0.3 g.kg-1BM of NaHCO3 (Intralabs, UK) in clear gelatine 107 
capsules. Supplements were independently tested by HFL Sports Science, UK, ensuring no 108 
contamination with steroids or stimulants according to ISO 17025 accredited tests.  109 
 110 
Fingertip capillary blood was obtained before participants ingested NaHCO3 with 500 ml of water.  111 
Following ingestion, blood was obtained every 10 min for 1 h, and then every 15 min for a further 2 h, 112 
during which time participants rested in a seated position. 80 µL of whole blood was collected in a 113 
heparin-coated clinitube (Radiometer Ltd, UK), and immediately analysed for pH, bicarbonate and Na+ 114 
concentrations with base excess being calculated (Radiometer ABL 900, UK).  115 
 116 
Statistical Analysis 117 
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Based on an a priori power calculation (using Ducker et al. 2013); a minimum of 12 participants were 118 
required to achieve 95% power at P<0.01, with 18 participants recruited to allow for dropouts. Statistical 119 
analyses were completed using SPSS version 22 (SPSS Inc., Chicago, IL, USA) and Microsoft Excel 120 
(Microsoft Inc., USA). Data were analysed using two-way (condition X time) repeated measures 121 
ANOVA. Assessed variables were tested for normality using the Shapiro–Wilks test, and for 122 
homogeneity using the Levene test. A Greenhouse-Geisser correction was applied when Mauchly’s test 123 
indicated that sphericity assumptions were violated. Blood analytes at each time-point were compared 124 
using a one-way ANOVA, with significance based on Bonferroni-corrected p-values.  Net area under 125 
the curve (AUC) was calculated (as per Gannon et al. 1989), and compared using a one-way ANOVA 126 
with Bonferroni-corrected post hoc analysis. Linear regression analyses were performed to investigate 127 
relationships between baseline and absolute changes in bicarbonate concentrations. Statistical 128 
significance was accepted at P≤0.05, with data presented as mean ± 1 standard deviation (SD).  129 
130 
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RESULTS 131 
The AUC was significantly greater for bicarbonate (0.1 g.kg-1BM: 314.4±96.1 mmol.L-1.180min-1; 0.2 132 
g.kg-1BM: 697.7±122.8 mmol.L-1.180min-1, 0.3 g.kg-1BM: 915.7±182.2 mmol.L-1.180min-1), pH (0.1 133 
g.kg-1BM: 5.05±2.60 pH units.180min-1; 0.2 g.kg-1BM: 9.03±2.93 pH units.180min-1; 0.3 g.kg-1BM: 134 
10.35±3.97 pH units.180min-1), base excess (0.1 g.kg-1BM: 379.6±122.0 mEq.L-1.180min-1; 0.2 g.kg-135 
1BM: 824.4±156.7 mEq.L-1.180min-1; 0.3 g.kg-1BM: 1078.6±210.3 mEq.L-1.180min-1) and Na+ (0.1 g.kg-136 
1BM: -48.7±195.7 mmol.L-1.180min-1; 0.2 g.kg-1BM: 111.4±223.5 mmol.L-1.180min-1; 0.3 g.kg-1BM: 137 
358.6±292.5 mmol.L-1.180min-1) following 0.3 g.kg-1BM compared to 0.2 g.kg-1BM (with the exception 138 
of pH responses; P≤0.05) and 0.1 g.kg-1BM doses (P≤0.05).  Overall responses to 0.2 g.kg-1BM were 139 
significantly greater than 0.1 g.kg-1BM (P≤0.05). 140 
 141 
Baseline bicarbonate (F(2,30)=2.0; P=0.20), pH (F(2,30)=0.7; P≤0.51), base excess (F(2,30)=1.7; P≤0.20) and 142 
Na+ (F(2,30)=0.3; P≤0.78) levels (Table 1) were not significantly different between doses. There was a 143 
significant main effect of time for bicarbonate (F(14,210)=72.6; P≤0.001), pH (F(14,210)=39.8; P≤0.001), 144 
base excess (F(14,210)=70.5; P≤0.001) and Na+ (F(14,210)=11.3; P≤0.001) levels, with increases following 145 
NaHCO3 ingestion under all supplemental conditions (Table 1).  146 
 147 
There was a significant main effect of NaHCO3 dose on bicarbonate (F(2,30)=53.0; P≤0.001), pH 148 
(F(2,30)=18.4; P≤0.001), base excess (F(2,30)=56.2; P≤0.001) and Na+ (F(2,30)=27.0; P≤0.001) levels. Post 149 
hoc analysis showed that the responses of all blood analytes were significantly lower following 0.1 g.kg-150 
1BM than following 0.2 g.kg-1BM (all P≤0.001 with the exception of pH [P>0.05]) and 0.3 g.kg-1BM 151 
doses (P≤0.003; Table 1). Bicarbonate concentrations (P≤0.01) and base excess (P≤0.001) were 152 
significantly higher following 0.3 g.kg-1BM compared to 0.2 g.kg-1BM, although there were no 153 
significant differences in pH and Na+ concentrations between these doses. There were significant dose 154 
by time interactions for bicarbonate (F(28,420)=17.2; P≤0.001), pH (F(28,420)=5.4; P≤0.001), base excess 155 
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(F(28,420)=18.4; P≤0.001), and Na+ (F(28,420)=5.0; P≤0.001) responses; time point comparisons for blood 156 
analytes are displayed in Table 1.  157 
 158 
Across each time interval there was large variability in the responses of blood analytes following each 159 
NaHCO3 dose (Table 1). From this point the results will focus solely on blood bicarbonate 160 
concentrations in the interests of brevity and given that this is the primary outcome measure of interest.  161 
With respect to bicarbonate concentrations, the greatest variability in responses occurred between ~20 162 
and 75 min after ingestion (Table 1). Variability was not reduced when data were normalised for body 163 
mass (data not shown). Individual blood bicarbonate responses are displayed in Figure 1.   164 
 165 
The absolute increases in bicarbonate concentrations from baseline to peak values (Figure 2) were 166 
significantly greater following the ingestion of 0.3 g.kg-1BM (8.2±1.4 mmol·L-1) than ingestion of 0.1 167 
g.kg-1BM (3.6±0.8 mmol·L-1; P≤0.001) or 0.2 g.kg-1BM (6.1±0.9 mmol·L-1; P≤0.001).  The magnitude 168 
of responses ranged from 2.0-5.0 mmol·L-1 for 0.1 g.kg-1BM, 5.1-8.1 mmol·L-1 for 0.2 g.kg-1BM and 169 
6.0-12.3 mmol·L-1 for 0.3 g.kg-1BM doses (Figure 2). One participant achieved an increase of 5 mmol·L-170 
1 from baseline, with none achieving an increase of 6 mmol·L-1 from baseline following 0.1 g.kg-1BM 171 
(Table 2). With the ingestion of 0.2 g.kg-1BM, all 16 participants achieved an increase of 5 mmol·L-1 172 
from baseline and 9 participants achieved an increase of 6 mmol·L-1 from baseline (Table 2).  All 173 
participants achieved an increase of 6 mmol·L-1 from baseline following the ingestion of 0.3 g.kg-1BM 174 
(Table 2).  175 
 176 
Individual magnitudes of responses between baseline and peak values were ranked, with only three 177 
participants (1, 7 and 10) consistently in the greatest 8 responders and three participants (4, 6 and 15) 178 
consistently in the least 8 responders on each dose (Table 2).  The magnitudes of the responses were 179 
more consistent within participants when comparing 0.2 and 0.3 g.kg-1BM doses (Table 2); 6 180 
participants (1, 7, 9, 10, 12, 16) were in the greatest 8 responders and 6 participants (4, 6, 8, 13, 14, 15) 181 
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were in the least 8 responders.  There was a significant difference in time-to-peak blood bicarbonate 182 
concentrations (F(2,30)=15.7, P≤0.001) between doses (Table 2). The time between ingestion and peak 183 
responses of blood bicarbonate demonstrated high inter-individual variability, with times ranging from 184 
30-150 min (mean: 78 min; CoV: 44%) following 0.1 g.kg-1BM, 40-165 min (mean: 98; CoV: 32%) 185 
following 0.2 g.kg-1BM and 75-180 min (mean: 123 min; CoV: 29%) following 0.3 g.kg-1BM. No 186 
relationship between baseline bicarbonate concentrations and the subsequent increase in response to 187 
NaHCO3 supplementation was shown for any dose (0.1 g.kg-1BM: R2=0.01; 0.2 g.kg-1BM: R2=0.19; 0.3 188 
g.kg-1BM: R2=0.01).   189 
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DISCUSSION 190 
This is the first study to report blood analyte responses from 15 time points over 3 hrs, with a high 191 
temporal frequency of sampling, following NaHCO3 ingestion at three differing doses. Despite 192 
individualising NaHCO3 dosing (based on individual body mass) a high degree of inter-individual 193 
variability existed with regards to the magnitude of change in blood analyte levels and the time to peak. 194 
The magnitude of the increase in blood analytes was dose-dependent, with greater increases achieved 195 
with larger doses of NaHCO3, although the range in responses was also greater at these highest dose. 196 
These data challenge the most commonly suggested supplementation protocol of 0.3 g.kg-1BM 197 
administered ~60 min prior to performance (McNaughton, 1991; Siegler et al. 2012; Duncan et al. 198 
2014), which is unlikely to result in optimal blood biochemistry for all individuals. It is difficult to 199 
compare the time-course relationship following ingestion due to existing data being focused on either 200 
pre- to post-exercise comparisons, or due to infrequent sample collection (Renfree et al. 2007; Siegler 201 
et al. 2010; Carr et al. 2011; Miller et al. in press).  Here we extend previous work examining the effect 202 
of NaHCO3 ingestion on acid-base responses (Renfree et al. 2007; Siegler et al. 2010; Carr et al. 2011; 203 
Miller et al. in press), by employing a much greater temporal resolution (every 10 min) in sampling.  204 
The mean time-to-peak for bicarbonate and pH responses following ingestion of 0.3 g.kg-1BM was 205 
greater than the 60-90 min previously documented (Renfree, 2007; Price & Singh, 2008; Siegler et al. 206 
2010); even when ingesting smaller doses (>60 min). Time-to-peak for all variables increased in a step-207 
wise manner relative to dose; blood pH peaked at 75 (0.1 g.kg-1BM), 105 (0.2 g.kg-1BM) and 120 min 208 
(0.3 g.kg-1BM) post-ingestion. Our data suggest that the time intervals used in previous studies might 209 
lead to some misinterpretation of findings relating to optimal blood analyte responses.  It remains 210 
unclear as to why high variability exists in time-to-peak when ingestion of NaHCO3 was conducted 211 
within a small and structured time period (10 min). Numerous factors which could explain this 212 
variability, thus providing an avenue for future investigation. 213 
 214 
If we use the 6 mmol·L-1 above baseline cut-off for blood bicarbonate responses, as suggested by Carr 215 
et al. (2011) to provide an ergogenic effect, it is clear that a dose of 0.3 g.kg-1BM remains the most 216 
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relevant to ensure that all individuals reach this zone (Figure 2). Following 0.3 g.kg-1BM, absolute 217 
changes in blood bicarbonate ranged between 6.0 and 12.3 mmol.L-1, with time-to-peak varying 218 
between 75 and 180 min. This demonstrates that the time taken for individuals to achieve peak 219 
concentrations or even performance relevant blood bicarbonate changes (Carr et al. 2011) is highly 220 
variable, suggesting a need to consider individual responses to NaHCO3 supplementation (Figure 1). 221 
Practically, an a priori knowledge of an individual’s blood responses following ingestion is required to 222 
optimise outcomes. What is not yet clear is whether or not individuals respond consistently to the same 223 
dose of NaHCO3 or what factors influence bicarbonate release (e.g., nutritional impact of gastric 224 
emptying), providing an avenue for further work.  225 
 226 
The current investigation might also help to explain discrepancies previously shown in relation to the 227 
ergogenic effect of NaHCO3 ingestion (for review see Carr et al. 2011), where numerous 228 
methodological differences relating dosing strategy were employed. In the current study, to provide 229 
consistency, participants were instructed to consume all capsules within 10 min, as per Siegler et al. 230 
(2010). The time taken to ingest NaHCO3 is often unreported or is >30 min (Carr et al. 2011), which 231 
would theoretically cause more variability in individual peak responses that those reported in the current 232 
study, as such comparisons to previous blood analyte responses are confounded. Gastric emptying has 233 
shown considerable inter-individual variation (Paintaud et al. 1998; Barbosa et al. 2005), although there 234 
is some consistency in intra-individual responses (Paintaud et al. 1998; Barbosa et al. 2005). These 235 
findings suggest that it might be important to replicate dietary intake prior to ingestion in order to 236 
develop a more consistent response to NaHCO3 ingestion. Participants in the current investigation 237 
replicated their 24 h dietary intake and remained fasted for 4 hrs prior to supplementation, where 90% 238 
of food would be emptied from the stomach (Tougas et al. 2000). Meal volume, composition and texture 239 
would, however, influence gastric emptying rates (Donohoe et al. 2009). An overnight fast would not 240 
be representative of athlete behaviour and so we decided to use a 4 h fast to provide a balance between 241 
experimental control and ecological validity. It should, however, be noted that the results of future 242 
studies might differ with alternative dietary intake patterns. During the current investigation non-243 
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arterialised fingertip capillary blood samples have been used to assess blood analyte responses. The PO2 244 
values for the current investigation were 75.38 ± 2.14 for the 0.1 g.kg-1BM condition, 74.14 ± 2.61 for 245 
0.2 g.kg-1BM and 73.18 ± 2.63 for the 0.3 g.kg-1BM condition as an average across all time points. Non-246 
warmed capillary blood samples are a useful and practical tool, reporting a strong correlation with 247 
arterial samples for pH, HCO3 and base excess variables (Yildizdas et al. 2004). This method is also in-248 
line with a number of previous investigations (Price & Simons, 2010; Bellinger et al. 2012; Siegler et 249 
al. 2013; Saunders et al. 2014). In a small independent study, we confirmed that blood arterialisation 250 
via warming the hand in a water bath (42oC) for 10 minutes did not alter blood gas parameters. 251 
Nonetheless, it is important to suggest caution when comparing non-arterialised with arterialised 252 
samples. 253 
 254 
Blood bicarbonate concentrations were similar over the first 30 min following ingestion of all  NaHCO3 255 
doses; blood pH also followed a similar pattern for the first 60 min post-ingestion. These findings 256 
questions the use of doses above 0.1 g.kg-1BM when the time between ingestion and performance is 257 
relatively short (i.e., following a high-intensity warm-up or when an athlete has multiple events over a 258 
short period of time), especially when the same level of bicarbonate manipulation is achievable. In these 259 
situations it would also be advisable to consume 0.1 g.kg-1BM of NaHCO3, given that lower doses 260 
reduce the intensity and/or frequency of negative GI symptoms (McNaughton, 1992; Kahle et al. 2013), 261 
which would benefit athletes in the competitive setting.  Some athletes require co-ingestion of NaHCO3 262 
with food and fluid in order to reduce GI symptoms, therefore lowering the dose could lead to a 263 
reduction in the amount of food/fluid ingested, vital for athletes competing numerous times within a 264 
short period.   265 
 266 
Following large quantities of NaHCO3, carbonic acid formation occurs in the stomach and Na+ 267 
absorption and Na+ plasma concentration both increase (Heigenhauser, 1991). As the physiochemical 268 
equilibrium shifts, water and CO2 increase in the blood, thereby increasing CO2 partial pressure (as 269 
described by the Henderson-Hasselbalch equation). This mechanism alters the already acidic 270 
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environment of the stomach, which can result in GI distress, including stomach bloating, nausea, and 271 
diarrhoea (McNaughton, 1992; Siegler et al. 2012).  In the present study following NaHCO3 ingestion 272 
we have shown increased plasma Na+ concentrations, with the mean change being two times greater 273 
following 0.3 g.kg-1BM (4 mmol.L-1) compared to 0.1 g.kg-1BM (2 mmol.L-1). The peak change in Na+ 274 
concentrations following 0.2 and 0.3 g.kg-1BM occurred ~105 minutes post-ingestion, which broadly 275 
corresponds to the timeframe of the greatest incidence of GI distress (~90 min following ingestion; Carr 276 
et al. 2011). The inter-individual variability in the magnitude of change in Na+ concentrations might 277 
explain why some individuals report GI distress, whilst others do not, even at the same NaHCO3 dose. 278 
 279 
In conclusion, the present data challenges the most commonly implemented NaHCO3 supplementation 280 
protocol and its efficacy to enhance buffering capacity and exercise performance for all individuals. 281 
Due to the large inter-individual responses shown, individual and mean responses should be included 282 
in future research and knowledge of the individual responses to NaHCO3 supplementation is essential 283 
in the applied setting. For individuals needing to ingest NaHCO3 ≤30 min prior to the onset of exercise, 284 
smaller doses can be ingested with no negative consequences for the additional extracellular buffering 285 
potential.  286 
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TABLES 407 
Table 1: Blood bicarbonate, pH, base excess and Na+ responses across the 3 h duration following 408 
NaHCO3 ingestion. Mean time point comparisons are displayed for each blood analyte; X denotes a 409 
significant difference between 0.1 and 0.2 g.kg-1BM. ∆ denotes a significant difference between 0.2 and 410 
0.3 g.kg-1BM. All comparisons are based on Bonferroni-corrected p-values of ≤0.003.    411 
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     Time post ingestion (min) 
      0 10 20 30 40 50 60 75 90 105 120 135 150 165 180 
B
ic
a
rb
o
n
a
te
 (
m
m
o
l.
L
-1
) 
0.1 g.kg-
1BM 
Mean 25.7 25.5 26.4 27.1  27.5
* 27.9*   28.0*X   27.9*X   28.0*X   28.1*X   27.9*X   27.4*X   27.4*X   27.2*X   27.2*X 
SD 1.0 1.2 1.7 1.8 1.9 1.9 1.6 1.3 1.0 1.2 1.1 1.1 1.1 0.8 0.7 
0.2 g.kg-
1BM 
Mean 25.1 25.3 25.9 27.3 28.4 28.9 29.5 30.1  30.5∆  30.5∆  30.1∆  29.9∆  29.6∆  29.3∆  29.1∆ 
SD 0.87 1.27 1.58 1.74 1.71 1.62 1.19 1.04 0.97 0.85 1.19 1.18 1.24 0.84 0.92 
0.3 g.kg-
1BM 
Mean 25.5 25.6 26.7 27.9 29.4 30.0 30.6 31.7 32.1 32.3 32.4 32.2 32.2 31.7 31.4 
SD 1.34 1.40 1.65 1.80 1.90 1.96 2.06 1.94 1.98 1.87 2.14 1.89 2.26 1.53 1.40 
p
H
 
0.1 g.kg-
1BM 
Mean 7.42 7.43 7.44 7.44 7.45 7.46  7.46
*  7.46*   7.46*X  7.46*   7.45*X   7.45*X  7.45*  7.45* 7.44 
SD 0.01 0.02 0.03 0.02 0.03 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.03 0.02 0.02 
0.2 g.kg-
1BM 
Mean 7.42 7.42 7.43 7.45 7.46 7.47 7.47 7.47 7.48 7.48 7.48 7.48 7.48 7.47 7.46 
SD 0.02 0.02 0.03 0.03 0.03 0.04 0.03 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 
0.3 g.kg-
1BM 
Mean 7.42 7.42 7.44 7.45 7.47 7.48 7.48 7.49 7.50 7.50 7.50 7.50 7.49 7.49 7.49 
SD 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.03 0.03 0.02 
B
a
se
 E
x
ce
ss
 (
m
E
q
. L
-1
) 
0.1 g.kg-
1BM 
Mean 1.59 1.32 2.51  3.37
*  3.84* 4.28*X   4.35*X   4.23*X   4.45*X   4.48*X   4.23*X   3.73*X   3.63*X   3.51*X   3.47*X 
SD 1.29 1.54 2.02 2.23 2.27 2.25 1.93 1.70 1.26 1.41 1.30 1.28 1.28 0.92 0.84 
0.2 g.kg-
1BM 
Mean 0.96 1.12 1.71 3.43 4.71 5.28  6.09
∆  6.68∆  7.18∆  7.29∆  6.90∆  6.74∆  6.40∆  6.16∆  5.87∆ 
SD 1.10 1.55 1.86 2.10 2.11 2.00 1.57 1.30 1.24 1.04 1.32 1.40 1.49 1.08 1.11 
0.3 g.kg-
1BM 
Mean 1.44 1.53 2.89 4.34 6.01 6.76 7.54 8.66 9.07 9.34 9.58 9.22 9.29 8.75 8.43 
SD 1.66 1.76 2.05 2.25 2.26 2.35 2.41 2.23 2.31 2.12 2.38 2.09 2.43 1.68 1.53 
N
A
+
 (
m
m
o
l.
L
-1
) 0.1 g
.kg-
1BM 
Mean 143 142 142 142 143 143 142
* 143*X 142*X 143* 142* 143*X 143*X 142* 142* 
SD 1 1 2 2 1 1 1 1 1 1 2 1 1 1 1 
0.2 g.kg-
1BM 
Mean 142 141 142 142 143 143 143 143 144 144 144 144 143 143 143 
SD 2 1 2 2 2 2 2 1 1 2 1 2 1 1 1 
0.3 g.kg-
1BM 
Mean 142 142 142 143 144 144 144 145 145 145 145 145 145 145 145 
SD 2 3 2 2 2 2 2 2 1 1 1 1 2 1 2 
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Table 2: Individual blood bicarbonate responses following NaHCO3 ingestion across supplemental condition. Absolute and percentage change in 412 
bicarbonate responses refer to the difference between baseline and peak concentrations; absolute changes of ≥5 mmol.L-1 are highlighted in bold. 413 
Position based on response ranks participants on absolute change in descending order, highest response equates to 1, whilst lowest absolute change 414 
equates to 16. Significant differences between supplementation conditions for absolute change and time-to-peak are denoted by * (0.1 and 0.3 g.kg-415 
1BM) X (0.1 and 0.2 g.kg-1BM) and ∆ (0.2 and 0.3 g.kg-1BM; P≤0.05).  416 
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  0.1 g.kg-1BM 0.2 g.kg-1BM 0.3 g.kg-1BM 
Participant 
number 
Baseline 
(mmol.L-1) 
Absolute 
Change 
(mmol.L-1) 
Percentage  
change  
(%) 
Time-
to-peak 
(min) 
Position 
based on 
response 
Baseline 
(mmol.L-1) 
Absolute 
Change 
(mmol.L-1) 
Percentage  
change  
(%) 
Time- 
to-peak 
(min) 
Position 
based on 
response 
Baseline 
(mmol.L-1) 
Absolute 
Change 
(mmol.L-1) 
Percentage  
change 
(%) 
Time- 
to-peak 
(min) 
Position 
based on 
response 
1 23.7 3.9 16.5 90 5 23.2 6.9 29.7 90 3 23.7 8.9 37.6 165 2 
2 25.1 4.4 17.5 50 3 25.7 6.0 23.3 90 8 24.8 8.9 35.9 90 3 
3 25.9 2.7 10.4 120 14 25.5 6.0 23.5 120 9 25.5 8.1 31.8 105 10 
4 24.6 2.0 8.1 90 16 23.9 5.5 23.0 105 12 25.4 7.0 27.6 90 12 
5 25.3 3.8 15.0 120 6 24.7 5.6 22.7 105 10 25.1 8.5 33.9 150 7 
6 25.9 3.1 12.0 90 12 25.2 5.3 21.0 120 13 25.2 6.9 27.4 150 14 
7 25.1 3.8 15.1 50 7 24.9 6.4 25.7 90 6 27.1 8.8 32.5 120 4 
8 26.6 4.9 18.4 105 2 25.7 5.1 19.8 105 15 28.5 7.7 27.0 120 11 
9 26.6 2.6 9.8 75 15 25.3 7.1 28.1 120 2 26.7 12.3 46.1 150 1 
10 24.9 4.3 17.3 150 4 24.9 6.6 26.5 135 5 23.1 8.6 37.2 180 6 
11 25.0 3.1 12.4 90 13 24.9 6.4 25.7 90 7 24.2 7.0 28.9 180 13 
12 26.4 3.3 12.5 50 10 24.5 8.1 33.1 90 1 25.9 8.6 33.2 105 5 
13 24.9 5.0 20.1 30 1 26.7 5.5 20.6 40 11 26.7 6.0 22.5 90 16 
14 27.6 3.7 13.4 50 8 26.6 5.2 19.5 165 14 26.1 8.3 31.8 120 9 
15 26.8 3.2 11.9 40 11 25.1 5.1 20.3 60 16 24.9 6.6 26.5 75 15 
16 26.2 3.4 13.0 50 9 25.2 6.7 26.6 50 4 25.4 8.4 33.1 75 8 
Mean 25.7     3.6 
*X 14.0   78 *   25.1   6.1 ∆ 24.3   98 ∆   25.5 8.2 32.0 123  
SD 1.0 0.8 3.3 34   0.9 0.9 3.9 32   1.3 1.4 5.6 36  
Min 23.7 2.0 8.1 30   23.2 5.1 19.5 40   23.1 6.0 22.5 75  
Max 27.6 5.0 20.1 150   26.7 8.1 33.1 165   28.5 12.3 46.1 180   
417 
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FIGURE LEGENDS 
Figure 1: Individual blood bicarbonate responses across the 3 hr following NaHCO3 ingestion at  0.1(A), 
0.2 (B) and 0.3 g.kg-1BM (C).  
 
Figure 2: Mean absolute change in bicarbonate concentrations across 15 intervals (3 hr) following 
ingestion of 0.1 (open circles), 0.2 (solid square) and 0.3 g.kg-1BM (open triangle) of NaHCO3. Zone of 
ergogenic effect (+6 mmol.L-1) is based on concentrations from Carr et al. (2011).   
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